{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:06:19Z","timestamp":1789005979622,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Postdoctoral Fellowship Program of the China Postdoctoral Science Foundation","award":["GZC20241142"],"award-info":[{"award-number":["GZC20241142"]}]},{"name":"the Postdoctoral Research Fund of West China Hospital, Sichuan University","award":["2025HXBH115"],"award-info":[{"award-number":["2025HXBH115"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82402249"],"award-info":[{"award-number":["82402249"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82102022"],"award-info":[{"award-number":["82102022"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82071874"],"award-info":[{"award-number":["82071874"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the 1-3-5 Project for Disciplines of Excellence, West China Hospital, Sichuan University","award":["ZYGD23019"],"award-info":[{"award-number":["ZYGD23019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06152-6","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T01:14:18Z","timestamp":1782436458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serial cardiac MR assessment and histopathological evaluation of doxorubicin-induced cardiomyopathy in a miniature swine model"],"prefix":"10.1186","volume":"26","author":[{"given":"Rui","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-chao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9341-7697","authenticated-orcid":false,"given":"Zhi-gang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"6152_CR1","first-page":"414","volume":"27","author":"K Ghasemi","year":"2021","unstructured":"Ghasemi K, Vaseghi G, Mansourian M. Pharmacological interventions for preventing anthracycline-induced clinical and subclinical cardiotoxicity: A network meta-analysis of metastatic breast cancer. J Oncol Pharm Pract. 2021;27:414-427","journal-title":"metastatic breast cancer"},{"key":"6152_CR2","first-page":"148","volume":"24","author":"A Ferrera","year":"2023","unstructured":"Ferrera A, Fiorentini V, Reale S, Solfanelli G, Tini G, Barbato E, et al. Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know. Rev Cardiovasc Med. 2023;24:148","journal-title":"Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know"},{"key":"6152_CR3","doi-asserted-by":"crossref","unstructured":"Boen HM, Cherubin M, Franssen C, Gevaert AB, Witvrouwen I, Bosman M, et al. Circulating MicroRNA as Biomarkers of Anthracycline-Induced Cardiotoxicity: JACC: CardioOncology State-of-the-Art Review. JACC CardioOncol. 2024;6:183\u2013199.","DOI":"10.1016\/j.jaccao.2023.12.009"},{"key":"6152_CR4","first-page":"38","volume":"6","author":"H Fonoudi","year":"2024","unstructured":"Fonoudi H, Jouni M, Cejas RB, Magdy T, Blancard M, Ge N, et al. Functional Validation of Doxorubicin-Induced Cardiotoxicity-Related Genes. JACC CardioOncol. 2024;6:38\u201350.","journal-title":"-related genes"},{"key":"6152_CR5","doi-asserted-by":"publisher","first-page":"111708","DOI":"10.1016\/j.biopha.2021.111708","volume":"139","author":"PS Rawat","year":"2021","unstructured":"Rawat PS, Jaiswal A, Khurana A, Bhatti JS, Navik U. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed Pharmacother. 2021;139:111708","journal-title":"Pharmacotherapy"},{"key":"6152_CR6","doi-asserted-by":"crossref","unstructured":"Yu D, Xiong J, Gao Y, Li J, Zhu D, Shen X, et al. Resveratrol activates PI3K\/AKT to reduce myocardial cell apoptosis and mitochondrial oxidative damage caused by myocardial ischemia\/reperfusion injury. Acta Histochem. 2021;123:151739","DOI":"10.1016\/j.acthis.2021.151739"},{"key":"6152_CR7","doi-asserted-by":"crossref","unstructured":"Gerodias FR, Jr., Tan MK, De Guzman A, Bernan A, Locnen SA, Apostol-Alday A, et al. Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Five-Year Retrospective Study in 10 Centers. Cardiol Res. 2022;13:380\u2013392.","DOI":"10.14740\/cr1442"},{"key":"6152_CR8","doi-asserted-by":"crossref","unstructured":"Becker MMC, Arruda GFA, Berenguer DRF, Buril RO, Cardinale D, Brand\u00e3o SCS. Anthracycline cardiotoxicity: current methods of diagnosis and possible role of (18)F-FDG PET\/CT as a new biomarker. Cardiooncology. 2023;9:17","DOI":"10.1186\/s40959-023-00161-6"},{"key":"6152_CR9","doi-asserted-by":"crossref","unstructured":"Jeyaprakash P, Sangha S, Ellenberger K, Sivapathan S, Pathan F, Negishi K. Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Placebo Arms From Randomized Controlled Trials. J Am Heart Assoc. 2021;10:e018802","DOI":"10.1161\/JAHA.120.018802"},{"key":"6152_CR10","doi-asserted-by":"crossref","unstructured":"Posch F, Niedrist T, Glantschnig T, Firla S, Moik F, Kolesnik E, et al. Left ventricular ejection fraction and cardiac biomarkers for dynamic prediction of cardiotoxicity in early breast cancer. Front Cardiovasc Med. 2022;9:933428","DOI":"10.3389\/fcvm.2022.933428"},{"key":"6152_CR11","first-page":"180","volume":"343","author":"I Harries","year":"2021","unstructured":"Harries I, Berlot B, Ffrench-Constant N, Williams M, Liang K, De Garate E, et al. Cardiovascular magnetic resonance characterisation of anthracycline cardiotoxicity in adults with normal left ventricular ejection fraction. Int J Cardiol. 2021;343:180\u2013186.","journal-title":"ejection fraction"},{"key":"6152_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jacc.2018.11.046","volume":"73","author":"C Gal\u00e1n-Arriola","year":"2019","unstructured":"Gal\u00e1n-Arriola C, Lobo M, V\u00edlchez-Tschischke JP, L\u00f3pez GJ, de Molina-Iracheta A, P\u00e9rez-Mart\u00ednez C, et al. Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity. J Am Coll Cardiol. 2019;73:779\u201391.","journal-title":"J Am Coll Cardiol"},{"key":"6152_CR13","doi-asserted-by":"crossref","unstructured":"Nakata K, Kucukseymen S, Cai X, Yankama T, Rodriguez J, Sai E, et al. Cardiovascular magnetic resonance characterization of myocardial tissue injury in a miniature swine model of cancer therapy-related cardiovascular toxicity. J Cardiovasc Magn Reson. 2024;26:101033","DOI":"10.1016\/j.jocmr.2024.101033"},{"key":"6152_CR14","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jacc.2018.11.045","volume":"73","author":"AF Yu","year":"2019","unstructured":"Yu AF, Chan AT, Steingart RM. Cardiac Magnetic Resonance and Cardio-Oncology: Does T(2) Signal the End of Anthracycline Cardiotoxicity? J Am Coll Cardiol. 2019;73:792\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"6152_CR15","first-page":"e021631","volume":"10","author":"GC Gabriel","year":"2021","unstructured":"Gabriel GC, Devine W, Redel BK, Whitworth KM, Samuel M, Spate LD, et al. Cardiovascular Development and Congenital Heart Disease Modeling in the Pig. J Am Heart Assoc. 2021;10:e021631.","journal-title":"Cardiovasc Dev congenital heart disease Model pig"},{"key":"6152_CR16","first-page":"25","volume":"22","author":"M Sturek","year":"2020","unstructured":"Sturek M, Alloosh M, Sellke FW. Swine Disease Models for Optimal Vascular Engineering. Annu Rev Biomed Eng. 2020;22:25\u201349.","journal-title":"Swine disease models optimal vascular Eng"},{"key":"6152_CR17","doi-asserted-by":"crossref","unstructured":"Wang D, Xu X, Zhao M, Wang X. Accelerated miniature swine models of advanced atherosclerosis: A review based on morphology. Cardiovasc Pathol. 2020;49:107241.","DOI":"10.1016\/j.carpath.2020.107241"},{"key":"6152_CR18","doi-asserted-by":"crossref","unstructured":"Niu M, Liu Y, Xiang L, Zhao Y, Yuan J, Jia Y, et al. Long-term case study of a Wuzhishan miniature pig with diabetes. Animal Model Exp Med. 2020;3:22\u201331.","DOI":"10.1002\/ame2.12098"},{"key":"6152_CR19","doi-asserted-by":"crossref","unstructured":"MacArthur Clark JA, Sun D. Guidelines for the ethical review of laboratory animal welfare People's Republic of China National Standard GB\/T 35892-2018 [Issued 6 February 2018 Effective from 1 September 2018]. Animal Model Exp Med. 2020;3:103\u2013113.","DOI":"10.1002\/ame2.12111"},{"key":"6152_CR20","doi-asserted-by":"crossref","unstructured":"Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22:17.","DOI":"10.1186\/s12968-020-00607-1"},{"key":"6152_CR21","doi-asserted-by":"crossref","unstructured":"Collins HE, Kane MS, Litovsky SH, Darley-Usmar VM, Young ME, Chatham JC, et al. Mitochondrial Morphology and Mitophagy in Heart Diseases: Qualitative and Quantitative Analyses Using Transmission Electron Microscopy. Front Aging. 2021;2:670267.","DOI":"10.3389\/fragi.2021.670267"},{"key":"6152_CR22","first-page":"670479","volume":"12","author":"EY Podyacheva","year":"2021","unstructured":"Podyacheva EY, Kushnareva EA, Karpov AA, Toropova YG. Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician. Front Pharmacol. 2021;12:670479.","journal-title":"Mod view perspective pathophysiologist clinician"},{"key":"6152_CR23","doi-asserted-by":"crossref","unstructured":"Farhad H, Staziaki PV, Addison D, Coelho-Filho OR, Shah RV, Mitchell RN, et al. Characterization of the Changes in Cardiac Structure and Function in Mice Treated With Anthracyclines Using Serial Cardiac Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2016;92016;9(12).","DOI":"10.1161\/CIRCIMAGING.115.003584"},{"key":"6152_CR24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mri.2022.01.019","volume":"90","author":"S Wang","year":"2022","unstructured":"Wang S, Zhu T, Wang C, Wang L, He B, Gao F. Identifying early stages of doxorubicin-induced cardiotoxicity in rat model by 7.0 tesla cardiovascular magnetic resonance combining hematological and pathological parameters. Magn Reson Imaging. 2022;90:17\u201325.","journal-title":"Magn Reson Imaging"},{"key":"6152_CR25","first-page":"1","volume":"7","author":"CV Noel","year":"2021","unstructured":"Noel CV, Rainusso N, Robertson M, Romero J, Masand P, Coarfa C, et al. Early detection of myocardial changes with and without dexrazoxane using serial magnetic resonance imaging in a pre-clinical mouse model. Cardiooncology. 2021;7:23.","journal-title":"mouse model"},{"key":"6152_CR26","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"AR Lyon","year":"2022","unstructured":"Lyon AR, L\u00f3pez-Fern\u00e1ndez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43:4229\u2013361.","journal-title":"Eur Heart J"},{"key":"6152_CR27","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1093\/eurheartj\/ehaa006","volume":"41","author":"J L\u00f3pez-Send\u00f3n","year":"2020","unstructured":"L\u00f3pez-Send\u00f3n J, \u00c1lvarez-Ortega C, Zamora Au\u00f1on P, Bu\u00f1o Soto A, Lyon AR, Farmakis D, et al. Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry. Eur Heart J. 2020;41:1720\u20139.","journal-title":"Eur Heart J"},{"key":"6152_CR28","doi-asserted-by":"crossref","unstructured":"Brann A, Janvanishstaporn S, Greenberg B. Association of Prior Left Ventricular Ejection Fraction With Clinical Outcomes in Patients With Heart Failure With Midrange Ejection Fraction. JAMA Cardiol. 2020;5:1027\u20131035.","DOI":"10.1001\/jamacardio.2020.2081"},{"key":"6152_CR29","first-page":"269","volume":"16","author":"T Negishi","year":"2023","unstructured":"Negishi T, Thavendiranathan P, Penicka M, Lemieux J, Murbraech K, Miyazaki S, et al. Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy: 3-Year Results of the SUCCOUR Trial. JACC Cardiovasc Imaging. 2023;16:269\u2013278.","journal-title":"SUCCOUR trial"},{"key":"6152_CR30","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamacardio.2023.0494","volume":"8","author":"P Thavendiranathan","year":"2023","unstructured":"Thavendiranathan P, Shalmon T, Fan CS, Houbois C, Amir E, Thevakumaran Y, et al. Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer. JAMA Cardiol. 2023;8:524\u201334.","journal-title":"JAMA Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06152-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06152-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06152-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:15:44Z","timestamp":1789002944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06152-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6152"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06152-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"28 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Animal Research Committee (approval No. 2020062\u00a0A), which serves as the Institutional Animal Care and Use Committee (IACUC) of the institution. All animals were institutionally owned, and therefore informed consent from animal owners was not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"784"}}